Neil K. Singla

Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.

W. Chapman, N. Singla, F. Weaver, 2010, Journal of the American College of Surgeons.

A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.

G. Moneta, N. Singla, J. Ballard, 2009, Journal of the American College of Surgeons.

Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis.

M. Butine, W. Alexander, Jeffrey L. Ballard, 2011, Journal of the American College of Surgeons.